Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AGIOAgios Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $54.03M |
| Revenue, yoy | +48.0% |
| Net income | $412.78M |
| Net income, yoy | −161.3% |
| Net margin | -764.0% |
| Free cash flow | $377.29M |
| FCF margin | -698.3% |
| EPS, diluted | $7.12 |
Add another company.